메뉴 건너뛰기




Volumn 96, Issue 13, 2010, Pages 1073-1077

Use of drug eluting stents in ST segment elevation myocardial infarction

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; CLOPIDOGREL; HEPARIN; HIRULOG; TIROFIBAN;

EID: 77954225970     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.161422     Document Type: Review
Times cited : (9)

References (20)
  • 1
    • 0037417523 scopus 로고    scopus 로고
    • Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials
    • Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
    • (2003) Lancet , vol.361 , pp. 13-20
    • Keeley, E.C.1    Boura, J.A.2    Grines, C.L.3
  • 2
    • 23844482612 scopus 로고    scopus 로고
    • Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: Meta-analysis of randomized trials
    • Kastrati A, Dibra A, Eberle S, et al. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA 2005;294:819-25.
    • (2005) JAMA , vol.294 , pp. 819-825
    • Kastrati, A.1    Dibra, A.2    Eberle, S.3
  • 3
    • 33847167065 scopus 로고    scopus 로고
    • Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxeleluting stents in routine clinical practice: Data from a large twoinstitutional cohort study
    • Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxeleluting stents in routine clinical practice: data from a large twoinstitutional cohort study. Lancet 2007;369:667-78.
    • (2007) Lancet , vol.369 , pp. 667-678
    • Daemen, J.1    Wenaweser, P.2    Tsuchida, K.3
  • 4
    • 33847259689 scopus 로고    scopus 로고
    • Drug-eluting stent and coronary thrombosis: Biological mechanisms and clinical implications
    • Luscher TF, Steffel J, Eberli FR, et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 2007;115:1051-58.
    • (2007) Circulation , vol.115 , pp. 1051-1058
    • Luscher, T.F.1    Steffel, J.2    Eberli, F.R.3
  • 5
    • 17844395445 scopus 로고    scopus 로고
    • Tirofiban and sirolimus eluting stent vs. abciximab and bare-metal stent for acute myocardial infarction: A randomized trial
    • ▶ First randomised trial comparing SES to BMS in primary PCI for STEMI
    • Valgimigli M, Percoco G, Malagutti P, et al. Tirofiban and sirolimus eluting stent vs. abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. JAMA 2005;293:2109-17. ▶ First randomised trial comparing SES to BMS in primary PCI for STEMI.
    • (2005) JAMA , vol.293 , pp. 2109-2117
    • Valgimigli, M.1    Percoco, G.2    Malagutti, P.3
  • 6
    • 33748702281 scopus 로고    scopus 로고
    • Sirolimus-eluting versus uncoated stents in acute myocardial infarction
    • ▶ First large randomised trial comparing SES to BMS in primary PCI for STEMI
    • Spaulding C, Henry P, Teiger E, et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006;355:1093-104. ▶ First large randomised trial comparing SES to BMS in primary PCI for STEMI.
    • (2006) N Engl J Med , vol.355 , pp. 1093-1104
    • Spaulding, C.1    Henry, P.2    Teiger, E.3
  • 7
    • 42249090036 scopus 로고    scopus 로고
    • Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: The MULTISTRATEGY randomized trial
    • ▶ Randomised trial with broad inclusion criteria
    • Valgimigli M, Campo G, Percoco G, et al. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial. JAMA 2008;299:1788-99. ▶ Randomised trial with broad inclusion criteria.
    • (2008) JAMA , vol.299 , pp. 1788-1799
    • Valgimigli, M.1    Campo, G.2    Percoco, G.3
  • 8
    • 34247849437 scopus 로고    scopus 로고
    • Randomized trial of sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction (SESAMI)
    • ▶ Small randomised trial comparing SES and BMS in primary PCI for AMI
    • Menichelli M, Parma A, Pucci E, et al. Randomized trial of sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction (SESAMI). J Am Coll Cardiol 2007;49:1924-30. ▶ Small randomised trial comparing SES and BMS in primary PCI for AMI.
    • (2007) J Am Coll Cardiol , vol.49 , pp. 1924-1930
    • Menichelli, M.1    Parma, A.2    Pucci, E.3
  • 9
    • 38749154306 scopus 로고    scopus 로고
    • Sirolimuseluting stents versus bare-metal stents in patients with STsegment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION Intervention Study
    • ▶ Randomised study with an intravascular ultrasound substudy group
    • van der Hoeven BL, Liem SS, Jukema JW, et al. Sirolimuseluting stents versus bare-metal stents in patients with STsegment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION Intervention Study. J Am Coll Cardiol 2008;51:618-26. ▶ Randomised study with an intravascular ultrasound substudy group.
    • (2008) J Am Coll Cardiol , vol.51 , pp. 618-626
    • Van Der Hoeven, B.L.1    Liem, S.S.2    Jukema, J.W.3
  • 10
    • 33748690953 scopus 로고    scopus 로고
    • Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention
    • ▶ First randomised study comparing PES to BMS during primary PCI for STEMI
    • Laarman GJ, Suttorp MJ, Dirksen MT, et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 2006;355:1105-13. ▶ First randomised study comparing PES to BMS during primary PCI for STEMI.
    • (2006) N Engl J Med , vol.355 , pp. 1105-1113
    • Laarman, G.J.1    Suttorp, M.J.2    Dirksen, M.T.3
  • 11
    • 65649091641 scopus 로고    scopus 로고
    • Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction trial
    • ▶ Large randomised trial comparing PES and BMS during primary PCI for STEMI
    • Stone GW, Lansky AJ, Pocock SJ, et al. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction trial. N Engl J Med 2009;360:1946-59. ▶ Large randomised trial comparing PES and BMS during primary PCI for STEMI.
    • (2009) N Engl J Med , vol.360 , pp. 1946-1959
    • Stone, G.W.1    Lansky, A.J.2    Pocock, S.J.3
  • 12
    • 52649151888 scopus 로고    scopus 로고
    • Drug-eluting or bare-metal stents for acute myocardial infarction
    • ▶ Study using data from a high quality registry
    • Mauri L, Silbaugh TS, Garg P, et al. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med 2008;359:1330-42. ▶ Study using data from a high quality registry.
    • (2008) N Engl J Med , vol.359 , pp. 1330-1342
    • Mauri, L.1    Silbaugh, T.S.2    Garg, P.3
  • 13
    • 59749103515 scopus 로고    scopus 로고
    • Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events
    • Steg PG, Fox KA, Eagle KA, et al. Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events. Eur Heart J 2009;30:321-9.
    • (2009) Eur Heart J , vol.30 , pp. 321-329
    • Steg, P.G.1    Fox, K.A.2    Eagle, K.A.3
  • 14
    • 65249147145 scopus 로고    scopus 로고
    • Use of drug-eluting stents in acute myocardial infarction: A systematic review and metaanalysis
    • ▶ Review and meta-analysis of randomised studies and registries
    • Brar SS, Leon MB, Stone GW, et al. Use of drug-eluting stents in acute myocardial infarction: a systematic review and metaanalysis. J Am Coll Cardiol 2009;53:1677-89. ▶ Review and meta-analysis of randomised studies and registries.
    • (2009) J Am Coll Cardiol , vol.53 , pp. 1677-1689
    • Brar, S.S.1    Leon, M.B.2    Stone, G.W.3
  • 15
    • 33847741037 scopus 로고    scopus 로고
    • An analysis of data from studies on sirolimus-eluting stents versus bare-metal stents
    • Spaulding C, Daemen J, Boersma E, et al. An analysis of data from studies on sirolimus-eluting stents versus bare-metal stents. N Engl J Med 2007;356:989-97.
    • (2007) N Engl J Med , vol.356 , pp. 989-997
    • Spaulding, C.1    Daemen, J.2    Boersma, E.3
  • 16
    • 33748709423 scopus 로고    scopus 로고
    • Drug-eluting stents in acute myocardial infarction
    • Van de Werf F. Drug-eluting stents in acute myocardial infarction. N Engl J Med 2006;355:1169-70.
    • (2006) N Engl J Med , vol.355 , pp. 1169-1170
    • Van De Werf, F.1
  • 17
    • 36148983750 scopus 로고    scopus 로고
    • Prasugrel versus clopidogrel in patients with acute coronary syndromes
    • Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-15.
    • (2007) N Engl J Med , vol.357 , pp. 2001-2015
    • Wiviott, S.D.1    Braunwald, E.2    McCabe, C.H.3
  • 18
    • 60649112469 scopus 로고    scopus 로고
    • Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): Double-blind, randomised controlled trial
    • TRITON-TIMI 38 Investigators
    • Montalescot G, Wiviott SD, Braunwald E, et al. TRITON-TIMI 38 Investigators. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet 2009;373:723-31.
    • (2009) Lancet , vol.373 , pp. 723-731
    • Montalescot, G.1    Wiviott, S.D.2    Braunwald, E.3
  • 19
    • 33745960402 scopus 로고    scopus 로고
    • Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: Results from the PREMIER registry
    • ▶ Registry study analysing thienopyridine compliance after primary PCI for STEMI
    • Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 2006;113:2803e9. ▶ Registry study analysing thienopyridine compliance after primary PCI for STEMI.
    • (2006) Circulation , vol.113
    • Spertus, J.A.1    Kettelkamp, R.2    Vance, C.3
  • 20
    • 54949142220 scopus 로고    scopus 로고
    • Cardiovascular outcomes after a change in prescription policy for clopidogrel
    • Jackevicius CA, Tu JV, Demers V, et al. Cardiovascular outcomes after a change in prescription policy for clopidogrel. N Engl J Med 2008;359:1802e10.
    • (2008) N Engl J Med , vol.359
    • Jackevicius, C.A.1    Tu, J.V.2    Demers, V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.